Halozyme Therapeutics, Inc. (HALO)

69.22 -2.07 (-2.90%) USD  |  NASDAQ  |  Jan 23, 16:00
69.00 -0.22 (-0.32%) After-Hours: 20:00
More

Halozyme Therapeutics Value Score

Value Score Chart

View Value Score for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Value Score Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Y-Charts Value Score Definition

View Y-Charts Value Score Definition
Start Trial

The Value Score is YCharts proprietary measurement of value - how much an investor is getting for what he or she pays.

Read full definition.

Value Score Range, Past 5 Years

View Value Score Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Value Score Benchmarks

View Value Score Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. --
Stryker Corp. Upgrade
Skye Bioscience, Inc. --